Cancer Genetics Downloads
-
EDI - Human Fetuin-A ELISA Kit - Brochure
This ELISA (enzyme-linked immunosorbent assay) kit is intended for the quantitative determination of human Fetuin-A, also known as alpha-2-HS glycoprotein (AHSG), in serum, plasma, cell culture supernatant, tissue extraction and urine. The measurement of Fetuin-A in serum or plasma aids in the diagnosis of some cancers and genetically inherited deficiencies of this serum protein. This Fetuin-A ...
-
Explore Cancer-related Mutations with NGS
Further mutations may occur in the progeny of the cancer cell, leading to the development of tumour cell invasion and metastasis. The application of NGS provides a high-resolution and global view of the cancer genome in a high throughput manner, revealing several novel cancer-related genes and pathways. ...
By CD Genomics
-
Model RUO - FP195 15q22/6q21 - Gene Abnormalities Probe Detection Kit - Brochure
Chromosome 6q amplifications encompassing 6q21-22 have been observed in MM including the same region as in CLL. Amplification including band 15q22 has been reported in MM. The 15q22 specific FISH probe is optimized to detect copy numbers at 15q22. The 6q21 specific DNA region is optimized to detect copy numbers at 6q21 (Cremer et al, 2005, Genes Chrom Cancer, 44; 194-203). ...
-
Model IVD - FP195 15q22/6q21 - Gene Abnormalities Probe Detection Kit - Brochure
Chromosome 6q amplifications encompassing 6q21-22 have been observed in MM including the same region as in CLL. Amplification including band 15q22 has been reported in MM. The 15q22 specific FISH probe is optimized to detect copy numbers at 15q22. The 6q21 specific DNA region is optimized to detect copy numbers at 6q21 (Cremer et al, 2005, Genes Chrom Cancer, 44; 194-203). ...
-
Tempus xG - Brochure
Providing risk-assessment for hereditary cancer syndromes for patients and their families. xG+ (extended hereditary cancers): Covers genes associated with multiple hereditary cancer types, including common hereditary cancers (breast, ovarian, colorectal, endometrial, prostate, pancreatic) and others (renal/urinary tract, gastric, melanoma, thyroid, endocrine, sarcomas, central nervous system, ...
By Tempus
-
The Reasons for Choosing Our Cancer Panels
CD Genomics's cancer panels are predesigned panels for targeted sequencing of genes and mutations associated with multiple cancer diseases. CD Genomics utilizes targeted NGS sequencing technology to provide more efficient and accurate targeting of specific genes or mutations, and even to detect low-frequency variations in cancer-associated genes. ...
By CD Genomics
-
Why Cancer Panels Stand Out for Cancer Research
CD Genomics is an innovative sequencing and genotyping company. Our cancer panels are designed to address the practical needs of cancer-related studies. These panels are featured an innovative background cleaning technique that allows plenty of amplicons to be multiplexed in a single reaction pool, allowing a large number of cancer-related genes to be detected in a single assay. ...
By CD Genomics
-
Cancer Diagnostics Brochure
Identify clinically significant mutations in cancer-associated genes to optimize patient-specific ...
-
Gene Panel Brochure
Targeted panel enriched for clinically relevant genes and most commonly mutated cancer driver genes with additional genes of emerging clinical significance focused on immediately actionable mutations. ...
By Tempus
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you